.png)
La Jolla Labs
RNA therapeutics design and discovery platform
El Cajon, United States · Founded 2020 · $3.5M raised
- Headquarters
- El Cajon, California
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- lajollalabs.com
- Total Funding
- $3.5M
- Last Round
- $3.5M Series AOct 2021
- Rounds
- 1
About
Biotechnology company specializing in RNA-based therapeutics for rare and complex diseases. Leverages modern RNA biology, machine learning, and automation to design precision therapeutic candidates. Expertise includes antisense oligonucleotides (ASO), siRNA, and miRNA with cloud-based drug discovery tools.
Summary
La Jolla Labs is a Biotech company based in El Cajon, United States, founded in 2020. It has raised $3.5M in total across 1 round, most recently a $3.5M Series A round in Oct 2021. Investors include NFX.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2021
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...